Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001738266-19-000001
Filing Date
2019-02-06
Accepted
2019-02-06 10:06:12
Documents
1
Effectiveness Date
2019-02-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6511
  Complete submission text file 0001738266-19-000001.txt   7545
Mailing Address 6894 LAKEMONT CIRCLE WEST BLOOMFIELD MI 48323
Business Address 6894 LAKEMONT CIRCLE WEST BLOOMFIELD MI 48323 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001738266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-313905 | Film No.: 19570105